Press release
Nutrigenomics Market to Reach USD 1.85 Billion by 2034, Growing at 9.2% CAGR as Personalized Nutrition Redefines Health and Wellness
Subheadline:Rising awareness of gene-based nutrition, rapid growth in DNA testing, and the integration of AI-driven diet analytics are accelerating global expansion of the nutrigenomics market.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72618
Introduction
The Nutrigenomics Market is transforming how people approach health, wellness, and disease prevention.
Valued at USD 760 million in 2024, the market is projected to reach USD 1.85 billion by 2034, registering a CAGR of 9.2% during the forecast period.
Nutrigenomics-an emerging science that studies the interaction between genes, diet, and metabolism-enables the development of personalized nutrition plans that optimize health outcomes. Increasing prevalence of obesity, cardiovascular disease, and metabolic syndrome is fueling demand for gene-guided dietary interventions worldwide.
Key Players in the Market
The competitive ecosystem includes genetics startups, diagnostics providers, and established life-science companies investing in DNA-based nutrition testing.
Major players include:
• 23andMe Inc.
• Nutrigenomix Inc.
• DNAfit Life Sciences Ltd.
• GX Sciences Inc.
• Metagenics Inc.
• Nutrigenetics Ltd.
• GENEWAY SA
• Viome Life Sciences Inc.
• BASF SE (Human Nutrition Division)
• Wellness Genetics LLC
These companies are expanding portfolios to include AI-enhanced diet platforms, genomic databases, and microbiome-integrated testing for improved accuracy and personalization.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72618/nutrigenomics-market
Key Events in the Last Five Years
• 2020-2021: Pandemic-driven focus on immune health accelerated demand for nutrition-genomics kits and home saliva testing.
• 2022: 23andMe integrated wellness insights into its direct-to-consumer genetic reports.
• 2023: Viome Life Sciences launched the "Health Intelligence Test" combining microbiome and human gene expression analysis.
• 2024: AI-powered nutritional analytics platforms began partnering with healthcare providers for preventive nutrition programs.
Market Growth Rate
According to Exactitude Consultancy, the nutrigenomics market is expected to grow at a CAGR of 9.2% (2025-2034), propelled by:
• Rising consumer interest in personalized wellness.
• Advances in genomic sequencing technologies lowering testing costs.
• Expansion of digital health ecosystems integrating nutrition tracking and genetic data.
• Supportive government and research funding for preventive healthcare solutions.
Market Segments and Growth Analysis
The market is segmented by product type, application, and region.
By Product Type:
• Test Kits and Reagents
• Bioinformatics Platforms
• Services (Genetic Analysis and Nutritional Counseling)
By Application:
• Obesity Management
• Cardiovascular Health
• Diabetes and Metabolic Disorders
• Cancer Nutrition Support
• Anti-Aging and Sports Performance
• General Wellness and Preventive Care
By Region:
• North America: Largest share; strong adoption of DNA-based diet programs and health-tech innovation.
• Europe: Increasing regulatory focus on nutrigenetic testing quality and privacy compliance.
• Asia Pacific: Fastest-growing region, driven by rising middle-class health awareness and digital diagnostic startups.
• Latin America & MEA: Emerging market for personalized weight-management solutions.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72618
Key Market Drivers
1. Personalized Nutrition Demand:
Consumers are shifting from generic diet plans to gene-tailored meal strategies enhancing nutrient absorption and disease resistance.
2. Technological Advancement:
Next-generation sequencing (NGS) and bioinformatics improve genetic variant interpretation and report turnaround time.
3. AI and Machine Learning Integration:
Predictive models optimize diet plans using real-time biomarker data.
4. Preventive Healthcare Focus:
Governments and insurers increasingly promote nutrigenomics for long-term cost reduction in chronic disease management.
Recent Developments
• 2023: Nutrigenomix launched an expanded 70-gene panel for personalized dietary assessment.
• 2024: BASF Human Nutrition unveiled AI-based platforms for micronutrient recommendations in functional foods.
• 2024: DNAfit integrated wearable data with genetic insights for dynamic health coaching.
• 2024: Viome secured major funding to scale personalized supplements manufactured from individual genomic and microbiome profiles.
Expert Insight
"The convergence of nutrigenomics, AI, and digital health tracking is reshaping preventive medicine. We're entering an era where every meal can be genetically optimized for long-term wellness,"
- Dr. Amelia Lopez, Clinical Genomics Director, Harvard School of Public Health.
Conclusion
The Nutrigenomics Market stands at the intersection of genetics, nutrition, and data science, heralding a future of truly individualized healthcare.
With growing consumer adoption, falling sequencing costs, and advances in bioinformatics, nutrigenomics is evolving from niche science into mainstream wellness.
As AI-powered analytics refine dietary personalization, the market is poised for dynamic growth and deeper integration into global preventive-care frameworks by 2034.
This report is also available in the following languages : Japanese (ニュートリゲノミクス市場), Korean (영양유전체학 시장), Chinese (营养基因组学市场), French (Marché de la nutrigénomique), German (Nutrigenomik-Markt), and Italian (Mercato della nutrigenomica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72618
Our More Reports:
Cell and Gene Therapy Manufacturing Market
https://exactitudeconsultancy.com/reports/72365/cell-and-gene-therapy-manufacturing-market
Joint Pain Injections Market
https://exactitudeconsultancy.com/reports/72379/joint-pain-injections-market
Medical Tourism Market
https://exactitudeconsultancy.com/reports/72397/medical-tourism-market
Compounding Pharmacy Market
https://exactitudeconsultancy.com/reports/72405/compounding-pharmacy-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nutrigenomics Market to Reach USD 1.85 Billion by 2034, Growing at 9.2% CAGR as Personalized Nutrition Redefines Health and Wellness here
News-ID: 4257329 • Views: …
More Releases from Exactitude Consultancy
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72069
Market Summary
The Partial Seizure Market…
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72067
Market Summary
The Partial…
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum.
Download Full PDF Sample Copy of Market…
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72063
Market Summary
The Prediabetes Market is expanding rapidly as healthcare…
More Releases for Nutrigenomics
Rethinking the Future: Nutrigenomics Market Expansion Strategies and Forecast In …
The most recent in-depth analysis from CoherentMI offers a comprehensive global perspective on the evolving Nutrigenomics Market, equipping industry stakeholders with data-backed insights into shifting market dynamics, innovation cycles, and emerging business models. This report serves as a trusted roadmap for organizations navigating a landscape shaped by increasing competition, technological disruption, and fluctuating demand across geographies. From strategic positioning to investment trends, the study provides clarity on both micro and…
Global Nutrigenomics Testing Market Size by Application, Type, and Geography: Fo …
According to Market Research Intellect, the global Nutrigenomics Testing market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Growing consumer awareness of the connection between genetics, nutrition, and general health is driving the demand for nutrigenomics…
Nutrigenomics Market 2025: Growth, Applications, Innovations and Business Outloo …
The Nutrigenomics Market is estimated to be valued at USD 1.3 Billion in 2024 and is expected to reach USD 3.07 Billion by 2031, growing at a compound annual growth rate (CAGR) of 13% from 2024 to 2031. Increased healthcare costs and rising focus on preventive healthcare are driving growth in the nutrigenomics market.
According to the latest research from CoherentMI, the Nutrigenomics Market is projected to experience significant growth…
Nutrigenomics Market Future Business Opportunities 2025-2032 | 3X4 Genetics,Adva …
The Nutrigenomics Market is estimated to be valued at USD 1.3 Billion in 2024 and is expected to reach USD 3.07 Billion by 2031, growing at a compound annual growth rate (CAGR) of 13% from 2024 to 2031.
The release of the report "Nutrigenomics Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2032". This includes examining past deployments, current market conditions, and expected future deployments. This study…
Nutrigenomics Market (2024-2031): Industry Insights, Market Size, Share, and Key …
According to a new report published by CoherentMI The Nutrigenomics Market is estimated to be valued at USD 1.3 Billion in 2024 and is expected to reach USD 3.07 Billion by 2031, growing at a compound annual growth rate (CAGR) of 13% from 2024 to 2031.
Most recent Report, named "Nutrigenomics Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a complete investigation of the business, which includes…
Latest Nutrigenomics Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Nutrigenomics industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Nutrigenomics market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Nutrigenomics report includes a professional in-depth study on the current…
